Login

EXACT SCIENCES CORP 3 SEC Filings

Filed On Filing
01 May 2025 Form 3: Trigg Leslie, Director

Holds 972 shares of Common Stock

06 Jan 2025 Form 3: Popovits Kimberly J, Director

No securities owned

17 Jun 2024 Form 3: Barber Michael J, Director

No securities owned

20 May 2024 Form 3: Bloomer Aaron, EVP, Chief Financial Officer
01 Nov 2023 Form 3: Scannell Timothy J, Director

No securities owned

30 Dec 2022 Form 3: Herriott James, General Counsel

Holds 8,612 shares of Common Stock

08 Aug 2022 Form 3: Baranick Brian, Gen. Mgr., Precision Oncology

Holds 2,868 shares of Common Stock

05 Nov 2021 Form 3: Cunningham Everett, Chief Commercial Officer
19 Mar 2021 Form 3: Clancy Paul J, Director

No securities owned

11 Jan 2021 Form 3: Condella Sarah, SVP, Human Resources

Holds 67,707 shares of Common Stock

11 Jan 2021 Form 3: Lidgard Graham Peter, Chief Science Officer

Holds 33,755 shares of Common Stock

11 Jan 2021 Form 3: Coward D Scott, Chief Administrative Officer

Holds 1,301 shares of Common Stock

24 Jul 2020 Form 3: Petrovic Shacey, Director

No securities owned

24 Apr 2020 Form 3: Lewis-Hall Freda C, Director

No securities owned

22 Apr 2020 Form 3: Paulsen Gisela, Gen Mgr, Precision Oncology

No securities owned

21 Nov 2019 Form 3: Cole G Bradley, General Manager - Diagnostics

Holds 70,548 shares of Common Stock

21 Nov 2019 Form 3: Orville Jacob A, General Manager, New Ventures
21 Nov 2019 Form 3: Hoof Torsten, General Manager, International

Holds 3,823 shares of Common Stock

07 Aug 2019 Form 3: Exact Sciences Corp, 10% owner · GENOMIC HEALTH INC

Holds 0 shares of common stock, par value $0.0001 per share

26 Jul 2019 Form 3: Slavitt Andrew M, Director

Holds 1,500 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support